03:39 PM EDT, 08/27/2024 (MT Newswires) -- Health care stocks were steady late Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both little changed.

The iShares Biotechnology ETF (IBB) eased 0.1%.

In corporate news, Cosciens Biopharma ( CSCI ) shares plunged 31% after the company said top-line results from a phase 3 trial assessing macimorelin to diagnose Childhood Onset Growth Hormone Deficiency showed the study didn't meet its primary efficacy endpoint.